Skip to main content
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

ETH-CAT

This article is a stubmissing:
Subjective Effects
Pharmacology
Interactions
Tolerance
History & Culture
ETH-CAT molecule structureETH-CAT molecule structure

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Threshold5-20 mg
Light15-35 mg
Moderate35-75 mg
Strong225-325 mg
Heavy300 mg

Although reports on ethylcathinone use are relatively scarce, available information indicates patterns consistent with other substituted cathinones. Compulsive redosing appears common, with users frequently combining routes of administration—for example, alternating between oral and insufflated doses within a single session. The urge to recapture initial effects often leads to subsequent doses that exceed the starting amount or are taken in rapid succession. Many experience reports describe difficulty resisting additional doses once effects begin to diminish, with some users unintentionally consuming a gram or more in a single session. Individual responses to any given dose can vary substantially, and what produces manageable effects in one person may be dangerous for another.

Duration

Onset15-45 minutes
Come Up15-30 minutes
Peak30-45 minutes
Offset30-90 minutes
After Effects2-4 hours
Total2-5 hours

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacology not written up yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Addiction & Dependence

Psychological

Moderate

Psychological dependence is possible given its euphoric stimulant effects profile. Many users report difficulty not redosing after strong doses, with experience reports of unexpectedly consuming a gram or more being common. Insufflation is particularly associated with compulsive use patterns.

Physical

Low

Unlikely to be physically addictive, with withdrawal symptoms expected to be minimal and not life-threatening.

Psychosis Risk

Abuse at high dosages for prolonged periods can potentially result in stimulant psychosis presenting with paranoia, hallucinations, or delusions. Approximately 5-15% of users who develop stimulant psychosis from amphetamine-class compounds fail to recover completely.

History & Culture

History & Culture not written up yet

Legality

International

Grey-area status is reported in many jurisdictions.

By Country

Illegal11
United States flagUnited StatesIllegal
Brazil flagBrazilIllegal
Canada flagCanadaIllegal (analog/blanket ban)
China flagChinaIllegal
Denmark flagDenmarkIllegal
Germany flagGermanyIllegal
Israel flagIsraelIllegal
Poland flagPolandIllegal
Sweden flagSwedenIllegal
Switzerland flagSwitzerlandIllegal
United Kingdom flagUnited KingdomIllegal

References

Citations

  1. Resolução da Diretoria Colegiada Anvisa nº 1.036, de 09/07/2026. anvisalegis.datalegis.net (n.d.). https://anvisalegis.datalegis.net/action/ActionDatalegis.php?acao=abrirTextoAto&tipo=RDC&numeroAto=00001036&seqAto=000&valorAno=2026&orgao=RDC/DC/ANVISA/MS&codTipo=&desItem=&desItemFim=&cod_menu=1696&cod_modulo=134&pesquisa=true1
  2. Resolução-RDC nº 49, de 11 de novembro de 2015. gov.br (n.d.). https://www.gov.br/anvisa/pt-br/assuntos/medicamentos/controlados/lista/arquivos-controlados/6560json-file-1/@@display-file/file1
  3. Portaria - PRT nº 344, de 12/05/1998. anvisalegis.datalegis.net (n.d.). https://anvisalegis.datalegis.net/action/ActionDatalegis.php?acao=abrirTextoAto&tipo=POR&numeroAto=00000344&seqAto=000&valorAno=1998&orgao=SVS/MS&codTipo=&desItem=&desItemFim=&cod_menu=1696&cod_modulo=134&pesquisa=true1
  4. Lei nº 11.343, de 23 de agosto de 2006 — texto atualizado. www2.camara.leg.br (n.d.). https://www2.camara.leg.br/legin/fed/lei/2006/lei-11343-23-agosto-2006-545399-normaatualizada-pl.html1
  5. Health Canada Drug Analysis Service and Cannabis Laboratory — HC DAS and CL classification framework for psychoactive substances in the illicit drug market (2026-07-06 substance list). health-infobase.canada.ca (n.d.). https://health-infobase.canada.ca/src/data/DAS/newLayout/20260706_ClassificationTable_Public.csv1
  6. Controlled Drugs and Substances Act, current consolidated Schedule I. laws-lois.justice.gc.ca (n.d.). https://www.laws-lois.justice.gc.ca/eng/acts/C-38.8/section-sched95314.html1
  7. Controlled Drugs and Substances Act, section 2 — Definitions. laws-lois.justice.gc.ca (n.d.). https://www.laws-lois.justice.gc.ca/eng/acts/C-38.8/section-2.html1
  8. Controlled Drugs and Substances Act, section 4 — Possession of substance. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/C-38.8/section-4.html1
  9. Controlled Drugs and Substances Act, section 5 — Trafficking in substance. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/C-38.8/section-5.html1
  10. Controlled Drugs and Substances Act, section 6 — Importing and exporting. laws-lois.justice.gc.ca (n.d.). https://laws-lois.justice.gc.ca/eng/acts/C-38.8/section-6.html1

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the ETH-CAT article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.